Compare Barclays PLC (BCS) vs GSK plc (GSK) Price & Performance

Barclays PLCTrade

GSK plcTrade

Price performance (Past 24H)

Key statistics

Barclays PLC vs GSK plc — how do they compare? Barclays PLC trades at $28 (market cap $93.87B), while GSK plc trades at $50.5 (market cap $102.60B). The key difference: Barclays PLC and GSK plc are close in size by market cap, and GSK plc pays the higher dividend (3.57%). Which is the better fit depends on your goals.

	BCS	GSK
Market Cap	$93.87B	$102.60B
Sector	Financials	Health
52-Week High	$28.56	$61.18
52-Week Low	$19.36	$38.22
Dividend Yield	2.19%	3.57%
Enterprise Value	—	$123.04B

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BCS

Barclays investors urged to join class action over alleged misleading info on mortgage exposure.GlobeNewsWire · 4 days agoBearish View details →

GSK

Trump orders splitting MMR vaccine into three shots despite no scientific support and expert criticism.CNBC · 22 hours agoBearish Theravance Biopharma to be acquired by Zymeworks in H2 2026; Q2 revenue up 11% on YUPELRI growth and cost cuts.PRNewsWire · 2 days agoBullish View details →

About Barclays PLC

Barclays is a universal bank headquartered in the United Kingdom. It operates via two principal segments

About GSK plc

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.